- 2017
-
Press releases - 08.06.2017
Cough syrup effective in stroke
N-acetylcysteine (Mucomyst®, Exomuc®, Fluimucyl®) is commonly used as a treatment for clearing mucus from the airways, but researchers from Inserm Unit 1237, “Physiopathology and Imaging of Neurological Disorders” (Inserm/ UNICAEN), led by Denis Vivien, have shown that it is also capable of unblocking arteries obstructed by a blood clot. This study, coordinated by Maxime Gauberti and Sara Martinez de Lizarrondo, opens the way to a new treatment strategy in stroke. The work was published in May in Circulation.
-
Press releases - 06.06.2017
Students at Increased Risk of Consuming Stimulants
With exam time looming, a certain number of students with intense workloads are succumbing to the use of stimulants to boost their intellectual capacities. Classified as psychotropics, stimulants are medicinal doping agents that boost the brain’s function by increasing its capacity for alertness and performance. A study by Inserm published in April 2016 showed that one third of the 1,700 medical students questioned were taking stimulants. Among them, 29.7% were consuming readily-available products (energy drinks, caffeine tablets), 6.7% prescribed stimulants, and 5.2% illicit drugs.
-
What's on? - 06.06.2017
Students at Increased Risk of Consuming Stimulants
With exam time looming, a certain number of students with intense workloads are succumbing to the use of stimulants to boost their intellectual capacities. Classified as psychotropics, stimulants are medicinal doping agents that boost the brain’s function by increasing its capacity for alertness and performance. Used to enhance memory and concentration at exam time, the […]
-
Press releases - 04.06.2017
Refractory cardiac arrest: an aggressive ECPR strategy significantly increases patient survival
Multidisciplinary teams from the AP-HP Paris public hospitals network (SAMU75 emergency response dispatch centers and Hôpital européen Georges-Pompidou), as well as from Inserm, the Université Paris-Descartes, and the Paris BSPP medical emergency service, compared, in the French capital, two strategies of extracorporeal cardiopulmonary resuscitation (ECPR) used in patients suffering refractory cardiac arrest (defined as lack of return of spontaneous circulation after 30 minutes of resuscitation). The results of this study, which took place between November 2011 and December 2015 and involved 156 patients, were published on the website of the journal Resuscitation on April 14, 2017 and show that an aggressive strategy significantly increases patient survival following discharge from intensive care and with a favorable neurological prognosis. It is the largest cohort to be studied in Europe and the United States.
-
Press releases - 02.06.2017
Twin Pregnancies in France: is Vaginal Delivery Preferable After All?
JUMODA, a prospective study sponsored by the Paris public hospitals (AP-HP) and conducted between 2014 and 2015 by teams of researchers and clinicians from Inserm, Université Paris Descartes and AP-HP, has shed new light on the mode of delivering twins. According to the coordinators of JUMODA (“MOde D’Accouchement des JUmeaux”), Professors Thomas Schmitz and François Goffinet, vaginal delivery is associated with decreased neonatal morbidity and mortality rates for both twins. These results have been published in the June issue of Obstetrics & Gynecology.
-
Press releases - 31.05.2017
The Imminent Return of Astronaut Thomas Pesquet
After 6 months of life in space as part of the Proxima mission, French ESA astronaut Thomas Pesquet will land on Friday, June 2, 2017, in the middle of the afternoon (4:08 p.m. Paris time), aboard the Soyuz capsule which is expected to touch down in the Kazakhstani steppes.
-
What's on? - 31.05.2017
The Imminent Return of Astronaut Thomas Pesquet
After 6 months of life in space as part of the Proxima mission, French ESA astronaut Thomas Pesquet will land on Friday, June 2, 2017, in the middle of the afternoon (4:08 p.m. Paris time), aboard the Soyuz capsule which is expected to touch down in the Kazakhstani steppes. On the station, he carried out […]
-
Press releases - 30.05.2017
Fecal incontinence : a novel therapy for a distressing condition
Inserm researchers in Rouen (Unit 1234 “PANTHER: Physiopathology, autoimmunity, neuromuscular diseases and regenerative therapies”, Inserm/Université de Rouen Normandie) have tested with success a cell therapy aiming to restore the ability of the sphincters to contract in patients with fecal incontinence. As part of a clinical study conducted in partnership with Rouen University Hospital, 60% of the patients who received this innovative therapy observed a reduction in their incontinence.
-
Press releases - 24.05.2017
An alternative route for cholesterol
Cholesterol plays a central role in many living processes. In a new study, a team led by Catherine-Laure Tomasetto, Inserm research director at the Institute of Genetics and Molecular and Cellular Biology (Inserm/CNRS/Université de Strasbourg) reveals the role played by the STARD3 protein in the distribution of cholesterol within cells. A little like molecular velcro, this protein has the capacity to form membrane contacts between two cell organelles, enabling it to transport cholesterol from one organelle to another.
-
What's on? - 24.05.2017
Wednesday May, 31: World MS Day
In a few days’ time, it will be World MS Day for which the theme this year is “Life with MS”. Multiple Sclerosis (MS) is an autoimmune disease that affects the central nervous system. It causes the progressive destruction of the myelin sheath surrounding the nerve cells, which is essential for their protection and for […]